Related Experiment Video
Updated: Apr 16, 2026

08:22
Orthotopic Left Lung Transplantation in Rats
Published on: July 3, 2025
917
Long-term lung transplantation in nonhuman primates.
1MGH Transplant Center, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
Summary
Developing a nonhuman primate model for lung transplantation is crucial for advancing graft tolerance. This study shows enhanced immunosuppression effectively prevents rejection in primates, paving the way for improved lung transplant outcomes.
Area of Science:
- Immunology
- Transplantation Biology
- Surgical Research
Background:
- Lung transplantation is a vital treatment for end-stage lung disease but faces challenges with graft longevity.
- Existing nonhuman primate models for lung transplantation are limited, hindering research into graft tolerance.
- Understanding primate-specific immune responses is key to improving lung transplant success.
Purpose of the Study:
- To establish a long-term nonhuman primate model for orthotopic lung transplantation.
- To investigate the propensity of nonhuman primate lungs towards rejection.
- To develop novel immunosuppression protocols to induce lung graft tolerance.
Main Methods:
- Development of an orthotopic lung transplantation model in nonhuman primates.
- Assessment of immune responses, including inflammation and T cell populations.
- Evaluation of standard triple-drug immunosuppression versus augmented protocols.
Main Results:
- Nonhuman primate lungs exhibit a high susceptibility to rejection.
- Upregulated inflammation and pre-existing alloreactive memory T cells contribute to rejection.
- Standard immunosuppression was insufficient; augmented protocols (anti-thymocyte globulin, IL-6 receptor antibody) prevented rejection in all recipients for over 120 days.
Conclusions:
- The nonhuman primate model is valuable for studying lung transplant rejection and tolerance.
- Enhanced immunosuppression strategies are necessary to overcome primate-specific immune barriers.
- This research provides a foundation for developing protocols to improve long-term lung allograft survival.

